kirazmattson
Member
Super Fildena — falls under a combination of laws and regulatory authorities. The Central Drugs Standard Control Organization (CDSCO) is the national regulatory body under the Ministry of Health & Family Welfare tasked with controlling drugs (licenses, standards) nationally. Wikipedia State‑level regulatory authorities (State Licensing Authorities) also regulate distribution, retail sale and enforcement under the D&C Act within their states. While the D&C Act and Rules cover drug sale, they do not explicitly provide for separate regulations for sale of medicines via online portals (at least as of now). Super Fildena Government has prepared draft rules titled “Sale of drugs by e‑pharmacy” (August 2018) which would require any online pharmacy to be registered with the Central Licensing Authority (via the CDSCO) before selling medicines online. Until such rules are formally notified, the legal position remains in a somewhat grey area — online sale is subject to the existing D&C Act and Rules, but there’s no separate fully‑notified regime giving full clarity. If an online portal is selling Super Fildena (which is a drug), it must comply with the same requirements as any retailer or pharmacy under the D&C Act/Rules (e.g., valid licence, prescription‑where required, correct storage/distribution). If the online seller is operating as an “e‑pharmacy” (distribution via web portal), then once the e‑pharmacy rules are notified, they would require registration with the CDSCO (or designated Central Licensing Authority) before selling. In practice: Consumers should check that the online pharmacy is licensed and operating legitimately. Unlicensed sale may breach the law and may carry risks (counterfeit, substandard drugs). So for Super Fildena sold online, regulation is by the same authorities (CDSCO + state drug controllers) though the “online” aspect is under a draft/transition phase.